TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

GENESIS VECTOR MANUFACTURING SOLUTIONS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

GENESIS VECTOR MANUFACTURING SOLUTIONS

ST13

US500000097705178

Classe

40, 42

Pedido

97705178

Registro

7393135

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

22

Atualização mais recente

21/05/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

40, 42

Data de depósito

06/12/2022

Data de registro

21/05/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

21/05/2024

Última transação

21/05/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

22/01/2024

Primeiro uso no comércio

22/01/2024

Código do desenho

4

Tipo de titular

16

Localização do titular

KING OF PRUSSIA, PA, US

Examinador

RUMMERY, MARY M

Unidade examinadora

M80

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC

Representantes

Joshua M. Gerben, Esq. GERBEN PERROTT, PLLC

Classificação técnica

Classes Nice

Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 40

Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals, plasmid DNA production; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting

Classe 42

Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research; research and development in the field of gene therapy acceleration, vector genome copy titers, droplet digital polymerase chain reaction (PCR) and digital polymerase chain reaction (PCR), mass spectrometry, capsid characterization, bioassays, plasmid DNA, and analytics testing in the field of genes and gene therapy

Publicações

Histórico de despachos e eventos da marca no USPTO.

22 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

21/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

21/05/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

18/04/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

17/04/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

29/02/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

29/02/2024

IUAF

USE AMENDMENT FILED

06/02/2024

EISU

TEAS STATEMENT OF USE RECEIVED

06/02/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

26/12/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

31/10/2023

PUBO

PUBLISHED FOR OPPOSITION

31/10/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/10/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/09/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/09/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

20/09/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

18/09/2023

GNRT

NON-FINAL ACTION E-MAILED

18/09/2023

CNRT

NON-FINAL ACTION WRITTEN

18/09/2023

DOCK

ASSIGNED TO EXAMINER

09/09/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/12/2022

NWAP

NEW APPLICATION ENTERED

09/12/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace GENESIS VECTOR MANUFACTURING SOLUTIONS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.